Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)

CUSIP: 207523101

Q2 2024 13F Holders as of 30 Jun 2024

Security identity
Shares outstanding
62,516,710
Holder snapshot
Share change
-970,923
Reported price per share
$1.52
Number of holders
12
Value change
-$1,478,482
Number of buys
3
Number of sells
5

Security key

207523101

Report period

Q2 2024

Institutions

12

Top holders

10

Ownership snapshot

Top reported holders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BML Capital Management, LLC
13D/G signal
Evidence rows
11
Latest as of
31 Mar 2024
13F Lead comparable stake: 3.3% Showing 1-6 of 11 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BML Capital Management, LLC
13F
Company
13F
3.3%
$3,586,728
2,061,338 shares
31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
1.7%
$1,809,717
1,040,067 shares
31 Mar 2024
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
13F
0.82%
$888,620
510,701 shares
31 Mar 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
0.38%
$417,000
239,900 shares
31 Mar 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.04%
$48,652
27,961 shares
31 Mar 2024
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
13F
0.03%
$35,000
20,000 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
12
Shares
2,976,236
Rows available
12
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
11
Q2 2024 holders
12
Holder diff
1
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .